Literature DB >> 18445007

Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.

Fabrice Cognasse1, Hind Hamzeh-Cognasse, Sandrine Lafarge, Patricia Chavarin, Bruno Pozzetto, Yolande Richard, Olivier Garraud.   

Abstract

B-cell expression of certain Toll-like receptors (TLRs) is important in linking innate and adaptive immune responses in normal and pathological conditions. The expression of TLR9 plays a role in the recognition of conserved pathogen motifs in a manner that is dependent on B-cell localization, deduced from B-cell phenotype. The nature of TLR9 function is unclear. A first step in unravelling the function of this pattern recognition receptor is to discover the precise nature of the cell types that express TLR9. This study used three-colour flow cytometry to characterize the B lymphocytes from human peripheral blood mononuclear cells (PBMCs) that express TLR9 on the surface. We sorted TLR9-positive B and non-B cells from the PBMC population and detected TLR9 expression on naïve and memory B cells. Moreover, we identified two discrete subpopulations of B cells: CD19(+) CD27(-) CD23(+) cells and CD19(+) CD27(high) CD80(+) cells. These subpopulations expressed high levels of membrane TLR9 and exhibited a strong in vitro response to binding a relevant CpG motif by secreting high levels of interleukin-6 (compared to controls). Our finding that this pattern recognition receptor is expressed on a variety of cell subsets adds to the current understanding of the functional complexity of B-cell membrane TLR9.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445007      PMCID: PMC2669146          DOI: 10.1111/j.1365-2567.2008.02844.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

2.  TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Benigno Rodriguez; Richard J Mohner; Scott F Sieg
Journal:  Eur J Immunol       Date:  2007-08       Impact factor: 5.532

3.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

4.  Interleukin-6 is a growth factor for nonmalignant human plasmablasts.

Authors:  G Jego; R Bataille; C Pellat-Deceunynck
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

Review 5.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts.

Authors:  Karin Tarte; John De Vos; Thomas Thykjaer; Fenghuang Zhan; Geneviève Fiol; Valérie Costes; Thierry Rème; Eric Legouffe; Jean-François Rossi; John Shaughnessy; Torben F Ørntoft; Bernard Klein
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

7.  HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals.

Authors:  F Cognasse; L Béniguel; R El Habib; O Sabido; P Chavarin; C Genin; O Garraud
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

8.  Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM.

Authors:  Yuhui Shi; Kazunaga Agematsu; Hans D Ochs; Kazuo Sugane
Journal:  Clin Immunol       Date:  2003-08       Impact factor: 3.969

9.  Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow.

Authors:  Julia I Ellyard; Danielle T Avery; Tri Giang Phan; Nathan J Hare; Philip D Hodgkin; Stuart G Tangye
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

Review 10.  Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.

Authors:  Petar S Lenert
Journal:  Arthritis Res Ther       Date:  2006-01-10       Impact factor: 5.156

View more
  16 in total

Review 1.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 2.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

3.  Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells.

Authors:  S Lafarge; H Hamzeh-Cognasse; Y Richard; B Pozzetto; M Cogné; F Cognasse; O Garraud
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  The CD27+ memory B cells display changes in the gene expression pattern in elderly individuals.

Authors:  Alicia Báez; Isabel Alvarez-Laderas; José I Piruat; Teresa Caballero-Velázquez; M Victoria Barbado; Africa Millán-Uclés; Mayte Medrano; Estefanía García-Guerrero; Li Sánchez-Abarca; José Antonio Pérez-Simón
Journal:  Immunology       Date:  2014-09-06       Impact factor: 7.397

Review 5.  Challenges in the pursuit of immune tolerance.

Authors:  Gerald T Nepom; E William St Clair; Laurence A Turka
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

6.  Mantle cell lymphoma activation enhances bortezomib sensitivity.

Authors:  Sarah K Brennan; Brooke Meade; Qiuju Wang; Akil A Merchant; Jeanne Kowalski; William Matsui
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

7.  CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine.

Authors:  Wenting Lu; Cuiyun Cui; Yangyang Wang; Xiaomeng Sun; Shengnan Wang; Ming Yang; Yongli Yu; Liying Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-05       Impact factor: 4.813

Review 8.  New insights into the regulation of human B-cell differentiation.

Authors:  Heike Schmidlin; Sean A Diehl; Bianca Blom
Journal:  Trends Immunol       Date:  2009-05-15       Impact factor: 16.687

9.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Authors:  Esmeralda Juarez; Carlos Nuñez; Eduardo Sada; Jerrold J Ellner; Stephan K Schwander; Martha Torres
Journal:  Respir Res       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.